SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (1067)11/30/2000 3:53:02 PM
From: Dan Spillane  Read Replies (1) of 1298
 
But looking at the cash, plus the investment in Abgenix, plus the prospects of CEGE itself and CEGE looks compelling--better than cash in many ways. Worth several times the current price.

People are incorrectly comparing biotechs to ".coms". The failed ".coms" lived for a few months, had a high burn rate, and no barriers to entry. Biotechs on the other hand have been around for years, just now coming up with profitable products involving years of accumulated research and thus high barriers--perhaps the highest.

Invalid comparison, biotechs to .coms ... hasn't CEGE been around for ten years or so!???!?

The ones I like are CEGE, RSTA, HGSI, and IMNX.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext